(ABSI) Absci - Performance -13% in 12m
ABSI performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-64.22%
#91 in Peer-Group
Rel. Strength
28.06%
#5343 in Stock-Universe
Total Return 12m
-12.96%
#71 in Peer-Group
Total Return 5y
-87.86%
#106 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 5.82 USD |
| 52 Week Low | 2.24 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 22.09 |
| Buy/Sell Signal +-5 | -1.75 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ABSI (-13%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: ABSI vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABSI
| Total Return (including Dividends) | ABSI | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -4.38% | 3.18% | 4.52% |
| 3 Months | 4.38% | 2.36% | 10.25% |
| 12 Months | -12.96% | -10.75% | 14.16% |
| 5 Years | -87.86% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | ABSI | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -23.2% | 30.9% | 79.1% |
| 3 Months | 2.1% | 63.2% | 91.7% |
| 12 Months | -59.1% | -83.8% | 44% |
| 5 Years | -37.6% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th41.50 | -7.32% | -8.52% |
| 3 Month | %th53.50 | 1.97% | -5.32% |
| 12 Month | %th65.00 | -2.47% | -23.76% |
| 5 Years | %th51.00 | -81.33% | -91.88% |
FAQs
Does Absci (ABSI) outperform the market?
No,
over the last 12 months ABSI made -12.96%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months ABSI made 4.38%, while XBI made 2.36%.
Performance Comparison ABSI vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ABSI vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -7.5% | -8.9% | -6.3% | -27% |
| US NASDAQ 100 | QQQ | -8.2% | -9.9% | -7.7% | -27% |
| German DAX 40 | DAX | -8.4% | -4.8% | -21.5% | -44% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.9% | -6.9% | -2.3% | -30% |
| Hongkong Hang Seng | HSI | -7.9% | -11.2% | -23.5% | -49% |
| India NIFTY 50 | INDA | -7.9% | -6.7% | -7.2% | -13% |
| Brasil Bovespa | EWZ | -6.8% | -7.9% | -27.9% | -23% |
ABSI vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8.7% | -11.3% | -12.6% | -41% |
| Consumer Discretionary | XLY | -7% | -6.3% | 1.7% | -33% |
| Consumer Staples | XLP | -4% | -3.2% | -5.2% | -22% |
| Energy | XLE | -4.2% | -8.9% | -3.6% | -10% |
| Financial | XLF | -7.3% | -6.9% | -9.5% | -41% |
| Health Care | XLV | -6.4% | -6.1% | 0.4% | -7% |
| Industrial | XLI | -7.1% | -7.5% | -13.1% | -36% |
| Materials | XLB | -6.2% | -6.7% | -7.1% | -16% |
| Real Estate | XLRE | -2.8% | -3.9% | -4.6% | -25% |
| Technology | XLK | -8.3% | -12.8% | -8.5% | -24% |
| Utilities | XLU | -5.2% | -5.4% | -10% | -37% |
| Aerospace & Defense | XAR | -9.4% | -14% | -27.4% | -65% |
| Biotech | XBI | -6% | -7.6% | 6.5% | -2% |
| Homebuilder | XHB | -6.2% | -8.3% | 4.2% | -14% |
| Retail | XRT | -5.3% | -6.5% | 1.1% | -20% |
ABSI vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1% | -13.4% | 0.93% | -3% |
| Natural Gas | UNG | -3.3% | -7.8% | 7.1% | -13% |
| Gold | GLD | -1.9% | -2.9% | -26.3% | -53% |
| Silver | SLV | -4% | -12% | -24.6% | -34% |
| Copper | CPER | -8.4% | -13% | -24.7% | -28% |
ABSI vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -5.8% | -6.2% | -2.4% | -14% |
| iShares High Yield Corp. Bond | HYG | -5.6% | -5.9% | -5.7% | -23% |